Following a crucial set of ruling from Mexico’s Supreme Court last week, the country’s leading political party will introduce a bill to establish a cannabis market for medical and recreational use.

On Tuesday (November 6) Reuters reported Senator Olga Sanchéz, the choice for interior minister by President-elect Andrés Manuel Lopéz Obrador, said the bill would be introduced in Congress on Thursday (November 8).


The bill suggests Mexico’s war policy against organized groups of drug dealers has failed in keeping people safer and the decriminalizing  the cannabis market.

“From a point of view of the negative side effects, there isn’t any reason for which cannabis isn’t illegal, while alcohol and tobacco are,” the document from the party of upcoming Mexican leader Morena, said.

The proposed bill seeks to legalize the entire industry and its relatives for medical, personal and scientific uses. The legislation was introduced as a response to the two new rulings from the Supreme Court in favor of cannabis use.

These two joined three previous rulings, which according to Mexican law, create a superimposition on the law followed by all courts in Mexico called jurisprudence.

With the bill is set to be presented on Thursday, it could face criticism from conservative groups in Congress. According to Reuters, the bill will have to pass committees before even reaching a voting stage.

Mexico would join Canada and Uruguay as the only nations to establish the legal use of cannabis for both medical and recreational purposes.

In the US, the drug has gained legality through legislation in the states. However, on a federal scale marijuana remains an illegal substance.

Investor takeaway

While it’s still early for investors to ponder which companies could benefit immediately, a variety of the leading Canadian LPs such as Canopy Growth (NYSE:CGC,TSX:WEED) and Aphria (NYSE:APHA,TSX:APHA) have made moves to establish a presence in the overall Latin American market.

Smaller companies such as Khiron Life Sciences (TSXV:KHRN) have also indicated a potential to enter the medical market in Mexico.

The potential for the country to establish a marketplace for a legitimate cannabis industry would add to the overall global trend of legalization for the drug.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Khiron Life Sciences is a client of the Investing News Network. This article is not paid-for content.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less